Sarcoidosis: a Critical Review of History and Milestones

Clinical Reviews in Allergy and Immunology

Volumn 49, Issue 1, 2015, Pages

  Spagnolo, Paolo ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cause; History; Initial description; Milestones; Sarcoidosis

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; MONOCLONAL ANTIBODY; THALIDOMIDE; TUMOR NECROSIS FACTOR;

BONE CYST; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ETHNIC DIFFERENCE; GENDER; GRANULOMA; HISTOPATHOLOGY; HUMAN; KVEIM TEST; LUNG BIOPSY; LUNG FIBROSIS; MEDICAL HISTORY; NEUROLOGIC DISEASE; RACE; RACE DIFFERENCE; REVIEW; SARCOIDOSIS; SKIN DISEASE; SYSTEMIC DISEASE; ADULT; EYE; FEMALE; HISTORY; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PATHOLOGY; PNEUMONIA; RADIOGRAPHY; SKIN;

ADULT; EYE; FEMALE; GRANULOMA; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PNEUMONIA; SARCOIDOSIS; SKIN;

EID: 84937640859     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-015-8480-0     Document Type: Review

References (20)

1. Sharma OP (2005) Definition and history of sarcoidosis. Eur Respir Mon 32:1–12
2. Hutchinson J (1898) Mortimer's malady. A form of lupus pernio. Arch Surg (London) 9:307–315
3. Besnier E (1889) Lupus Pernio de la Face. Ann Derm Syph (Paris) 10:33–36
4. Boeck C (1899) Multiple benign sarcoid of the skin. Norsk Mag Laegevid 14:1321–1345
5. Heerfordt CF (1909) Uber eine febris uveo-parotidea subchronica. Graefes Arch Ophthalmol 70:254–258
6. Schaumann J (1933) Etude anatomo pathologique et histologique sur les localisations viscerales de la lymphogranulomatose benigne. Bull Soc Fr Dermatol Syphiligr 1:167–322
7. Lofgren S (1953) Primary pulmonary sarcoidosis. Acta Med Scand 145:424–455
8. Kveim A (1941) On a new and specific cutaneous reaction in Boeck's sarcoid: a preliminary report. Nord Med 9:169–172
9. Siltzbach LE (1961) The Kveim test in sarcoidosis: a study of 750 patients. J Am Med Ass 178:476–482
10. Zissel G (2014) Cellular activation in the immune response of sarcoidosis. Semin Respir Crit Care Med 35:307–315
11. Noor A, Knox KS (2007) Immunopathogenesis of sarcoidosis. Clin Dermatol 25:250–258
12. Spagnolo P, Grunewald J (2013) Recent advances in the genetics of sarcoidosis. J Med Genet 50:290–297
13. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234
14. Spagnolo P, Richeldi L, du Bois RM (2008) Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. Semin Respir Crit Care Med 29:610–619
15. Statement on Sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. (1999). Am J Respir Crit Care Med. 160, 736-755
16. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241
17. Grunewald J, Eklund A (2009) Löfgren’s syndrome. Human Leukocyte Antigen strongly influences the disease course. Am J Respir Crit Care Med 179:307–312
18. Spagnolo P, du Bois RM (2007) Genetics of sarcoidosis. Clin Dermatol 25:242–249
19. Newman LS (2005) Aetiologies of sarcoidosis. Eur Respir Mon 32:23–48
20. Judson MA (2003) The etiologic agent of sarcoidosis. What if there isn’t one? Chest 124:6–8